Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
"A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly in Monotherapy or in Combination With One OAD in Japanese Subjects With Type 2 Diabetes (SUSTAIN)"
Rapid weight loss from GLP-1 medications can be accompanied by a loss of lean body mass
Chen Y-C, Chen T-H, Sun -C-C, et al
Your healthcare provider can assess whether continuing semaglutide with enhanced reflux control, switching to a different GLP-1 medication, or exploring oral formulations might better suit your needs
All patients had established cardiovascular disease (CVD), but no prior history of diabetes
Chest pain or heart palpitations
US$ 27.29
US$ 21.16
US$ 26.75
US$ 28.03
